These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 353464
21. [The different biochemical course of HBsAg-negative and HBsAg-positive hepatitis (author's transl)]. Strohm WD, Hossenfelder E, Stille W. Z Gastroenterol; 1978 Jan; 16(1):13-23. PubMed ID: 74913 [Abstract] [Full Text] [Related]
22. [Silymarin in the treatment of acute viral hepatitis]. Patera L. Cesk Gastroenterol Vyz; 1978 Dec; 32(8):533-4. PubMed ID: 737788 [No Abstract] [Full Text] [Related]
23. A comparative study of regression of jaundice in patients of malaria and acute viral hepatitis. Kochar DK, Kaswan K, Kochar SK, Sirohi P, Pal M, Kochar A, Agrawal RP, Das A. J Vector Borne Dis; 2006 Sep; 43(3):123-9. PubMed ID: 17024861 [Abstract] [Full Text] [Related]
24. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)]. Reutter FW, Haase W. Schweiz Rundsch Med Prax; 1975 Sep 09; 64(36):1145-51. PubMed ID: 1099576 [No Abstract] [Full Text] [Related]
25. [Serum levels of cholylglycine and sulfolitho-cholylglycine in the course of acute hepatitis (author's transl)]. Ohlen J, Richter J, Neiss A, Drescher M, Selmair H. Acta Med Austriaca; 1981 Sep 09; 7(2):49-51. PubMed ID: 7211138 [Abstract] [Full Text] [Related]
26. Low lipoprotein (a) levels during acute viral hepatitis. Geiss HC, Ritter MM, Richter WO, Schwandt P, Zachoval R. Hepatology; 1996 Dec 09; 24(6):1334-7. PubMed ID: 8938156 [Abstract] [Full Text] [Related]
27. Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study. Salmi HA, Sarna S. Scand J Gastroenterol; 1982 Jun 09; 17(4):517-21. PubMed ID: 6753109 [Abstract] [Full Text] [Related]
28. Normotest in acute viral hepatitis. Schmidt W, Gros H. Scand J Gastroenterol Suppl; 1973 Jun 09; 19():143-50. PubMed ID: 4515638 [No Abstract] [Full Text] [Related]
29. [Viral hepatitis A with atypical course. Clinical, biochemical, and virologic study of 7 cases]. Verucchi G, Calza L, Chiodo F. Ann Ital Med Int; 1999 Jun 09; 14(4):239-45. PubMed ID: 10638016 [Abstract] [Full Text] [Related]
30. [Membranotropic therapy of infantile viral hepatitis]. Andreuzzi A, Viola F. Minerva Pediatr; 1979 May 15; 31(9):733-40. PubMed ID: 460119 [No Abstract] [Full Text] [Related]
31. A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. El-Kamary SS, Shardell MD, Abdel-Hamid M, Ismail S, El-Ateek M, Metwally M, Mikhail N, Hashem M, Mousa A, Aboul-Fotouh A, El-Kassas M, Esmat G, Strickland GT. Phytomedicine; 2009 May 15; 16(5):391-400. PubMed ID: 19303273 [Abstract] [Full Text] [Related]
32. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis. Matsuzaki Y, Tanaka N, Osuga T, Aikawa T, Shoda J, Doi M, Nakano M. Am J Gastroenterol; 1990 Jan 15; 85(1):15-23. PubMed ID: 1967512 [Abstract] [Full Text] [Related]
33. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study. Cadranel JF, Di Martino V, Dorent R, Bernard B, Hoang C, Myara A, Pauwels A, Ghoussoub JJ, Perrin M, Grippon P, Thabut D, Trivin F, Huraux JM, Gandjbakhch I, Opolon P, Lunel F. Transplantation; 2003 Apr 15; 75(7):977-82. PubMed ID: 12698083 [Abstract] [Full Text] [Related]
34. [The use of silymarin and SAMe in the treatment of acute infective hepatitis in childhood]. Musso A, Giacchino M, Vietti M, Vaccino P, Cerutti A. Minerva Pediatr; 1980 Sep 15; 32(17):1057-67. PubMed ID: 7453688 [No Abstract] [Full Text] [Related]
36. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy. Rühl R, Seidensticker M, Peters N, Mohnike K, Bornschein J, Schütte K, Amthauer H, Malfertheiner P, Pech M, Ricke J. Dig Dis; 2009 Sep 15; 27(2):189-99. PubMed ID: 19546558 [Abstract] [Full Text] [Related]
37. Serum level of soluble intercellular adhesion molecule-1 in patients with acute viral hepatitis A or acute viral hepatitis B: lack of correlation with severity of the disease. Magiera M, Kucharz EJ, Chelmicka A, Moron-Swierszcz J, Witor A, Witor A, Kotulska A. Rom J Intern Med; 2009 Sep 15; 38-39():97-101. PubMed ID: 15529577 [Abstract] [Full Text] [Related]
38. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)]. Müzes G, Deák G, Láng I, Nékám K, Niederland V, Fehér J. Orv Hetil; 1990 Apr 22; 131(16):863-6. PubMed ID: 2345633 [Abstract] [Full Text] [Related]
39. [Sylimarol in the treatment of acute viral hepatitis]. Tkacz B, Dworniak D. Wiad Lek; 1983 Apr 15; 36(8):613-6. PubMed ID: 6353775 [No Abstract] [Full Text] [Related]
40. Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy. El-Zayadi AR, Attia M, Badran HM, El-Tawil A, Zalata K, Barakat E, Selim O, El-Nakeeb A, Saied A. Liver Int; 2005 Aug 15; 25(4):746-51. PubMed ID: 15998425 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]